independent prognosticator of actual warm ischemic time but not for functional warm ischemic time. Utilization of selected DCD donors with warm ischemic times > 2 hr should be considered.
INTRODUCTION AND OBJECTIVES: Kidney transplant (KT) is the best treatment for end-stage chronic kidney disease, with higher survival rates, better quality of life and lower economic burden than dialysis. Due to the large amount of people awaiting a KT there is a great organ shortage, which has led to investigate new sources of grafts. Donation after cardiac death (DCD) has emerged in the last two decades to increase the donor pool, classically composed by donation after brain death (DBD). Uncontrolled DCD (uDCD) is popular in scarce countries; these kidneys have a higher ischemic risk due to longer cold ischemia time, which can be related to a higher rate of postoperative complications, especially affecting the urinary reconstruction. Our aim is to compare the incidence of postoperative complications of uDCD transplants (with normothermic preservation prior to organ procurement) versus DBD transplants.
METHODS: We carried out a retrospective review of 300 KT (150 uDCD with normothermic perfusion and 150 DBD) performed in our centre between 2007 and 2012 on recipients under 60 years old. We collected preoperative features, surgical technique, graft characteristics and postoperative complications. These complications were also stratified according to time of onset (early -during the first 90 postoperative days-versus late -after the 90th postoperative day-) and severity (based on Clavien-Dindo classification). Data were analysed using Stata v12.0 for Windows.
RESULTS: Baseline characteristics were comparable, with a median follow-up of 53.6 months. Total postoperative complication rate was 77.7%. Comparative incidence of complications is presented in Table 1 and stratification is in Table 2. CONCLUSIONS: Uncontrolled DCD kidneys under normothermic preservation have a rate of postoperative complications comparable to that of DBD kidneys, with no differences in time of onset or severity. We therefore believe that postoperative complications are not an obstacle when it comes to use DCD kidneys as a source of grafts to fight against organ shortage.
Source of Funding: None.
MP30-18 RACIAL DISPARITIES IN RENAL TRANSPLANTATION
Benjamin Abelson*, Colette Harris, Cleveland, OH; Jamie Mitchell, Ann Arbor, MI; Songhua Lin, Charles Modlin, Cleveland, OH INTRODUCTION AND OBJECTIVES: African American (AA) patients have increased rates of end-stage renal disease compared to Caucasian American (CA) patients, and despite making up 13% of the American population, AAs comprise over 30% of the kidney transplantation list. This study seeks to better define our institutional experience in renal transplantation for AA patients in order to identify methods to reduce previously published racial disparities in access to and outcomes after renal transplantation.
METHODS: We retrospectively reviewed the most recent fifteen years of kidney transplants at our institution. Clinical and demographic characteristics were collected from the electronic medical record. Kaplan Meier curves were generated for patient and graft survival, stratified by race and by living versus deceased donor transplantation.
RESULTS: A total of 1840 kidney transplants were performed at our institution from 2000-2016, including 1393 CA patients and 447 AA patients. 944 of the transplants were from living donors (LD) and 846 were from deceased donors (DD). Among the 1393 transplants for CAs, 818 (59%) were from LDs, whereas among the 447 AA transplants, only 126 were LD transplants (28%, p<0.001). There was no difference in patient survival between AA and CA recipients of deceased donor recipients or living donor recipients. Graft survival was longer in CA recipients of DD transplants (mean number, p<0.0001) but there was no significance in the graft survival difference between AA and CA recipients of LD transplants (Figure 1) . CONCLUSIONS: Living donation confers a graft and overall survival advantage compared to DD, and this is true among both AA and CA patients. At our institution there is no significant difference in graft or patient survival between AA and CA patients after living donation, though after deceased donation CAs have improved graft and patient survival. Furthermore, there is a striking difference in utilization of LD transplant between AA and CA patients. This demonstrates the need for further study of why AA patients are severely underrepresented in LD transplants, and improved education and communication regarding living donation among the AA community.
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